Julia Meade, MD

  • Assistant Professor of Pediatrics
  • Director, Pediatric Cancer Predisposition Program

Administrative Assistant: Amanda Hall

Meade is a pediatric oncologist with additional fellowship training in the care of children with brain and spinal cord tumors.  Part of her clinical time is spent caring for children in the brain tumor survivorship program at UPMC Children’s Hospital of Pittsburgh.  Additionally, Meade sees children and families with cancer predisposition syndromes. 

Education & Training

  • BA, Wellesley College, 2005
  • MD, Texas A&M University Health and Science Center College of Medicine, 2011
  • Residency, University of Colorado, 2014
  • Fellowship, UT Southwestern Medical Center, 2017
  • Fellowship, Northwestern University/Lurie Children's Hospital, 2018

Selected Publications

Venier, R; Maurer, L; Kessler, E; Ranganathan, S.; McGough, R.; Weiss, K.; Malek, M.; Meade, J.; Tersak, J.; Bailey, K. 2019. A germline BARD1 mutation in a patient with Ewing Sarcoma: implications for familial testing and counseling. Jun 3. Pediatr Blood Cancer. PMID: 31157509

Algattas, H; Abou-Al-Shaar, H; Mendelson, M; Arnold, G; Felker, J; Meade, J; Greene, S. 2020. Familial Cerebral Cavernous Malformation Syndrome with concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence? Cancer Genetics, in revision

Bey, E; Meade, J; Silvers, M; Motea, E; Patidar, P; Brekken, R; Deja, S; Merritt, M; Kilgore, J; Liu, Y; Huang, X; Li, L; Yordy, J; Williams, N; Gao, J; Boothman, D. “NQO1 Bioactivatable Drugs Modify Radiation Responses.” (2016) M.S. Anscher, K. Valerie (Eds.), Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Springer International Publishing, Switzerland.

 

View ORCID Record ORCID » 

Academic and Research Interests

  • Pediatric Cancer Predisposition Syndromes
  • Pediatric Cancer Genetics
  • Rare Pediatric Cancers 
  • Neurofibromatosis